Exclusive

Publication

Byline

Location

Singapore Clinical Trial: A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the efficacy in reducing atrial fibrillation burden (AFB) as well as the safety, tolerability, and pharmacokinetics of oral PKN605 in participants with atrial fibrillation

Singapore, April 21 -- The Health Sciences Authority received information related to the study titled 'A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the eff... Read More


Singapore Clinical Trial: A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination with Osimertinib as First-Line Treatment in Patients with Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Singapore, April 21 -- The Health Sciences Authority received information related to the study titled 'A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab ... Read More


Singapore Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus and Participants with Overweight or Obesity without Type 2 Diabetes Mellitus.

Singapore, April 21 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Re... Read More


Singapore Clinical Trial: A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E

Singapore, April 21 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination W... Read More


Clinical Trial: Injectable Platelet-Rich Fibrin Versus Intradermal Tranexamic Acid for Melasma

U.S., April 21 -- ClinicalTrials.gov registry received information related to the study (NCT07540702) titled 'Injectable Platelet-Rich Fibrin Versus Intradermal Tranexamic Acid for Melasma' on April 1... Read More


Clinical Trial: Storybook-Based Nutrition Education for Preschoolers

U.S., April 21 -- ClinicalTrials.gov registry received information related to the study (NCT07540234) titled 'Storybook-Based Nutrition Education for Preschoolers' on July 31, 2025. Brief Summary: Th... Read More


Clinical Trial: Italian Multicenter Experience With Radioreceptor-assisted Therapy (PRRT)

U.S., April 21 -- ClinicalTrials.gov registry received information related to the study (NCT07538791) titled 'Italian Multicenter Experience With Radioreceptor-assisted Therapy (PRRT)' on April 13. B... Read More


Clinical Trial: Microgreens and miRNAs

U.S., April 21 -- ClinicalTrials.gov registry received information related to the study (NCT07540858) titled 'Microgreens and miRNAs' on April 15. Brief Summary: In this study, we investigated the im... Read More


Clinical Trial: Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe Myelofibrosis

U.S., April 21 -- ClinicalTrials.gov registry received information related to the study (NCT07539779) titled 'Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With ... Read More


Clinical Trial: Effect of Lactiplantibacillus Plantarum LM1001 on Muscle Strength in Older Adults

U.S., April 21 -- ClinicalTrials.gov registry received information related to the study (NCT07538830) titled 'Effect of Lactiplantibacillus Plantarum LM1001 on Muscle Strength in Older Adults' on Apri... Read More